Alex Zhavoronkov, founder & CEO of Insilico Medicine, stated that he “firmly believes that the repurposing of FDA-approved drugs with demonstrated anti-ageing potential represents a highly ...

The drug was given accelerated approval in the US in 2022, which was upgraded to full approval a year ago, and was also cleared in Europe last November. AbbVie has pointed to a very strong launch ...